Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Aphasia

NCT: NCT07791459 · NOT_YET_RECRUITING

NCT IDNCT07791459
StatusNOT_YET_RECRUITING
Start Date2026-08
Completion2038-12
SponsorLeigh R. Hochberg, MD, PhD. (OTHER)
First posted
Last updated

Brief Summary

The purpose of this study is to obtain preliminary device safety information and demonstrate proof of principle (feasibility) of the ability of people with aphasia to generate text on a computer screen and audible, computer-generated speech by attempting to speak.

Frequently Asked Questions

What is BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Aphasia?

BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Aphasia is a clinical trial registered under NCT07791459. Current status: NOT_YET_RECRUITING.

What is the status of NCT07791459?

The current status of NCT07791459 (BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Aphasia) is: NOT_YET_RECRUITING.

When did BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Aphasia start?

BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Aphasia started on 2026-08.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑